recombinant human activated protein C [HSA:5624] [KO:K01344]
treatment of sepsis, stroke, and acute thrombotic diseases with high mortality and/or morbidity
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AD Enzymes
B01AD10 Drotrecogin alfa (activated)
D03918 Drotrecogin alfa (activated) (USAN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01707 Fibrinolytic
D03918 Drotrecogin alfa (activated)